000			01793 a2200577 4500
005			20250516114202.0
264		0	_c20131205
008			201312s 0 0 eng d
022			_a1439-0507
024	7		_a10.1111/myc.12013 _2doi
040			_aNLM _beng _cNLM
100	1		_aBergamasco, M D
245	0	0	_aEpidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil. _h[electronic resource]
260			_bMycoses _cMay 2013
300			_a256-63 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmphotericin B _xtherapeutic use
650	0	4	_aAntifungal Agents _xtherapeutic use
650	0	4	_aBrazil _xepidemiology
650	0	4	_aCandida _xisolation & purification
650	0	4	_aCandidemia _xcomplications
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCross Infection
650	0	4	_aFemale
650	0	4	_aHematologic Neoplasms _xcomplications
650	0	4	_aHospital Mortality
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aIntensive Care Units
650	0	4	_aLength of Stay
650	0	4	_aMale
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xcomplications
650	0	4	_aRetrospective Studies
650	0	4	_aSeverity of Illness Index
650	0	4	_aSurvival Analysis
650	0	4	_aTertiary Care Centers
650	0	4	_aYoung Adult
700	1		_aGarnica, M
700	1		_aColombo, A L
700	1		_aNucci, M
773	0		_tMycoses _gvol. 56 _gno. 3 _gp. 256-63
856	4	0	_uhttps://doi.org/10.1111/myc.12013 _zAvailable from publisher's website
999			_c22164811 _d22164811